Steve Chui, M.D., Director of Breast Cancer Clinical Research, Knight Cancer Institute, was quoted in a recent 1190 KEX news article that reports that the Knight Cancer Institute is one of 20 cancer centers across the country selected to participate in a groundbreaking clinical trial aimed at testing the most promising drugs in development in women newly diagnosed with higher risk, rapidly growing breast cancers.

Read the article and listen to the audio report